期刊文献+

营养治疗在胰腺癌患者围术期的应用研究进展 被引量:2

Application progress of nutritional therapy in perioperative period of patients with pancreatic cancer
下载PDF
导出
摘要 胰腺癌围术期患者由于各种因素易出现营养不良。营养治疗对疾病发生、发展的影响越来越受到临床重视,提高患者术前和术后的营养状况可使更多患者受益。本文主要从围术期的全面性营养评估、术前及术后营养治疗进展和术后主要并发症等方面进行综述,以期更好地指导临床工作。 Patients with pancreatic cancer are prone to malnutrition due to various factors.The impact of nutritional therapy on the occurrence and development of diseases has received more and more clinical attention.Improving the nutritional status of patients before and after surgery can benefit more patients.This article mainly reviews the perioperative comprehensive nutritional assessment,preoperative and postoperative nutritional treatment progress,and postoperative major complications,in order to better guide clinical work.
作者 熊普 张尊月(综述) 王昆华(审校) XIONG Pu;ZHANG Zunyue;WANG Kunhua(National Health Commission Key Laboratory of Drug Addiction Medicine,Kunming Medical University,Kunming,Yunnan 650500,China;Department of Gastrointestinal and Hernia Surgery,the First Affiliated Hospital of Kunming Medical University,Kunming,Yunnan 650032,China;Yunnan Engineering Technology Center of Digestive Disease,Kunming,Yunnan 650032,China)
出处 《重庆医学》 CAS 2021年第2期328-332,共5页 Chongqing medicine
基金 国家自然科学基金-地区资助项目(31860306) 云南省卫生厅内设机构项目(2018NS0086) 云南省科技厅项目(2018DH006) 云南省云岭学者项目(YLXL20170002) 云南省普通外科疾病临床医学中心项目(ZX2019-03-03)。
关键词 胰腺肿瘤 围手术期 营养评价 营养疗法 pancreatic neoplasms perioperative period nutrition assessment nutritional therapy
  • 相关文献

参考文献5

二级参考文献37

  • 1Krastev Z, Koltchakov V, Tomov B,et al. Non-melanoma and non-renal cell carcinoma malignancies treated with interleukin-2. Hepatogastroenterology,2003,50(52):1006-1016
  • 2Faiss S, Pape UF, Bohmig M, et al. International Lanreotide and Interferon Alfa Study Group. Prospective,randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroend
  • 3Xu ZW, Kleeff J, Friess H, et al. Synergistic cytotoxic effect of TRAIL and gemcitabine in pancreatic cancer cells. Anticancer Res, 2003,23(1A):251-258
  • 4Tamamori Y, Sawada T, Nishihara T, et al. Granulocyte-colony stimulating factor enhances chimeric antibody Nd2 dependent cytotoxicity against pancreatic cancer mediated by polymorphonuclear neutrophils. Int J Oncol,2002,21(3):649-654
  • 5Calbo J, Marotta M, Cascallo M, et al. Adenovirus-mediated wt-p16 reintroduction induces cell cycle arrest or apoptosis in pancreatic cancer. Cancer Gene Ther, 2001,8(10):740-750
  • 6Wesseling JG, Yamamoto M, Adachi Y, et al. Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinoma. Cancer Gene Ther, 2001,8(12):990-996
  • 7Evoy D, Hirschowitz EA, Naama HA, et al. In vivo adenoviral-mediated gene transfer in the treatment of pancreatic cancer. J Surg Res, 1997,69(1):226-231
  • 8Pan X, Li ZS, Xu GM, et al. Adenovirus-mediated gene transfer in the treatment of pancreatic cancer. Pancreas, 2003,26(3):274-278
  • 9Chen L, Waxman DJ. Cytochrome P450 gene-directed enzyme prodrug therapy (GDEPT) for cancer. Curr Pharm Des, 2002,8(15):1405-1416
  • 10Carrio M, Visa J, Cascante A, et al. Intratumoral activation of cyclophosphamide by retroviral transfer of the cytochrome P450 2B1 in a pancreatic tumor model. Combination with the HSVtk/GCV system. J Gene Med, 2002,4(2):141-149

共引文献321

同被引文献25

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部